Literature DB >> 20495844

Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Guo-Long Zhang1, Yan-Feng Zou, Xiao-Liang Feng, He-Jian Shi, Xu-Feng Du, Min-Hua Shao, Yong Gu, Qing Zhou.   

Abstract

OBJECTIVE: To quantitatively summarize the association of NFKBIA gene polymorphisms with autoimmune and inflammatory diseases.
METHODS: We surveyed studies on the association of NFKBIA gene polymorphisms with autoimmune and inflammatory diseases in PubMed. Meta-analysis was performed in a fixed/random effect model.
RESULTS: We identified 14 studies using a PubMed search. Meta-analysis was performed for NFKBIA gene polymorphisms at positions 2758 (A/G, 5 studies), -881 (A/G, 3 studies), -826 (C/T, 3 studies), and -297 (C/T, 3 studies). We did not detect associations of NFKBIA gene polymorphisms at positions 2758, -881, -297 with autoimmune and inflammatory diseases. An association of NFKBIA gene -826C/T polymorphism with autoimmune and inflammatory diseases was found (C vs. T: OR = 1.81, 95% CI = 0.97-3.36, P = 0.06; CT + TT vs. CC: OR = 2.11, 95% CI = 1.07-4.19, P = 0.03; TT vs. CC + CT: OR = 2.20, 95% CI = 0.78-6.21, P = 0.06; TT vs. CC: OR = 2.87, 95% CI = 0.78-10.62, P = 0.11; CT vs. CC: OR = 2.02, 95% CI = 1.22-3.36, P = 0.006).
CONCLUSION: This meta-analysis demonstrates that autoimmune and inflammatory diseases are associated with NFKBIA gene -826C/T polymorphism, but not with 2758A/G, -881A/G, and -279C/T.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495844     DOI: 10.1007/s00011-010-0216-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium.

Authors:  John J Haddad; Stephen C Land
Journal:  Am J Respir Cell Mol Biol       Date:  2002-01       Impact factor: 6.914

Review 3.  The role of nuclear factor-kappa B in pulmonary diseases.

Authors:  J W Christman; R T Sadikot; T S Blackwell
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

Review 4.  The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma.

Authors:  J R Berenson; H M Ma; R Vescio
Journal:  Semin Oncol       Date:  2001-12       Impact factor: 4.929

5.  Lack of association of the 3'-UTR polymorphism in the NFKBIA gene with Crohn's disease in an Israeli cohort.

Authors:  E Leshinsky-Silver; A Karban; S Cohen; M Fridlander; O Davidowich; G Kimmel; R Shamir; A Levine
Journal:  Int J Colorectal Dis       Date:  2007-03-01       Impact factor: 2.571

Review 6.  The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment.

Authors:  Alina Kuryłowicz; Janusz Nauman
Journal:  Acta Biochim Pol       Date:  2008-12-16       Impact factor: 2.149

7.  Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.

Authors:  B Miterski; S Böhringer; W Klein; E Sindern; M Haupts; S Schimrigk; J T Epplen
Journal:  Genes Immun       Date:  2002-06       Impact factor: 2.676

8.  IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.

Authors:  Tsan-Teng Ou; Chia-Hui Lin; Yu-Chih Lin; Ruei-Nian Li; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2008-07-04       Impact factor: 8.317

9.  Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.

Authors:  M F Neurath; I Fuss; G Schürmann; S Pettersson; K Arnold; H Müller-Lobeck; W Strober; C Herfarth; K H Büschenfelde
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

10.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

Authors:  Ikuo Okafuji; Ryuta Nishikomori; Nobuo Kanazawa; Naotomo Kambe; Akihiro Fujisawa; Shin Yamazaki; Megumu Saito; Takakazu Yoshioka; Tomoki Kawai; Hidemasa Sakai; Hideaki Tanizaki; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Arthritis Rheum       Date:  2009-01
View more
  11 in total

1.  Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet.

Authors:  Jennifer A Crookshank; Christopher Patrick; Gen-Sheng Wang; J Ariana Noel; Fraser W Scott
Journal:  Immunology       Date:  2015-03-29       Impact factor: 7.397

2.  Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation.

Authors:  Monica Guma; Dariusz Stepniak; Helena Shaked; Martina E Spehlmann; Steve Shenouda; Hilde Cheroutre; Ildelfonso Vicente-Suarez; Lars Eckmann; Martin F Kagnoff; Michael Karin
Journal:  J Exp Med       Date:  2011-08-08       Impact factor: 14.307

3.  Single nucleotide polymorphism rs696 in miR449a binding site of NFKBIA gene is correlated with risk of colorectal cancer.

Authors:  Miganoosh Simonian; Meysam Mosallayi; Maryam Miraghajani; Awat Feizi; Sharifeh Khosravi; Ahmad Reza Salehi; Deniz Mortazavi; Farideh Saberi; Rasoul Salehi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

4.  Novel Insights reveal Anti-microbial Gene Regulation of Piglet Intestine Immune in response to Clostridium perfringens Infection.

Authors:  Xiao Yu Huang; Wen Yang Sun; Zun Qiang Yan; Hai Ren Shi; Qiao Li Yang; Peng Fei Wang; Sheng Gui Li; Li Xia Liu; Sheng Guo Zhao; Shuang Bao Gun
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

5.  Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis.

Authors:  Thatcha Yimthin; Jacqueline Margaret Cliff; Rungnapa Phunpang; Peeraya Ekchariyawat; Taniya Kaewarpai; Ji-Sook Lee; Clare Eckold; Megan Andrada; Ekkachai Thiansukhon; Kittisak Tanwisaid; Somchai Chuananont; Chumpol Morakot; Narongchai Sangsa; Wirayut Silakun; Sunee Chayangsu; Noppol Buasi; Nicholas Day; Ganjana Lertmemongkolchai; Wasun Chantratita; T Eoin West; Narisara Chantratita
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 6.  MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis.

Authors:  Mohammad Reza Karimzadeh; Maryam Zarin; Naeim Ehtesham; Sharifeh Khosravi; Mohsen Soosanabadi; Meysam Mosallaei; Peyman Pourdavoud
Journal:  Cancer Gene Ther       Date:  2020-03-23       Impact factor: 5.987

Review 7.  Association of IL-1Ra Ser133Ser Variant with Susceptibility to Immune-Mediated and Inflammatory Diseases: A Meta-Analysis of 2622 Cases and 3854 Controls.

Authors:  Mahdiyeh Harati-Sadegh; Saman Sargazi; Roghayeh Sheervalilou; Saeed Hosseini Teshnizi; Ramin Saravani; Shekoufeh Mirinejad
Journal:  Iran J Public Health       Date:  2020-12       Impact factor: 1.429

8.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

9.  The effect of nicotinamide on gene expression in a traumatic brain injury model.

Authors:  G D Anderson; T C Peterson; F M Farin; T K Bammler; R P Beyer; E D Kantor; M R Hoane
Journal:  Front Neurosci       Date:  2013-02-26       Impact factor: 4.677

10.  Neonatal pain-related stress and NFKBIA genotype are associated with altered cortisol levels in preterm boys at school age.

Authors:  Ruth E Grunau; Ivan L Cepeda; Cecil M Y Chau; Susanne Brummelte; Joanne Weinberg; Pascal M Lavoie; Mihoko Ladd; Aaron F Hirschfeld; Evan Russell; Gideon Koren; Stan Van Uum; Rollin Brant; Stuart E Turvey
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.